Liver cancer.

  title={Liver cancer.},
  author={{\'A}lvaro Aguayo and Yehuda Z. Patt},
  journal={Clinics in liver disease},
  volume={5 2},
The prognosis of patients with HCC remains dismal. Even in the subgroups of patients who have the most favorable characteristics and are eligible for surgical resection, the 5-year survival rate is less than 25%. For patients with more advanced disease, the median survival time is less than 1 year. The good news in HCC research is that the disease can be prevented. In Taiwan, the rate of HCC in children aged 6 to 9 years decreased from 5.2 per million population before the neonatal vaccination… CONTINUE READING